ArticleBMC complementary medicine and therapies2023

Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death.

Tarek El-Sewedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.